PSS25 Actinic Keratosis Patients are Willing to Pay for Shorter Treatment and Local Skin Response Duration and Ingenol Mebutate Gel is Likely to Increase Patient Likelihood of Successful Completion of Topical Treatment
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1369
https://www.valueinhealthjournal.com/article/S1098-3015(12)01434-9/fulltext
Title :
PSS25 Actinic Keratosis Patients are Willing to Pay for Shorter Treatment and Local Skin Response Duration and Ingenol Mebutate Gel is Likely to Increase Patient Likelihood of Successful Completion of Topical Treatment
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01434-9&doi=10.1016/j.jval.2012.03.1369
First page :
A254
Section Title :
Sensory Systems Disorders
Open access? :
No
Section Order :
907